<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>51</volume><submitter>Song IA</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>We aimed to investigate the prevalence and factors associated with long-term opioid use among patients with chronic non-cancer pain (CNCP).&lt;h4>Methods&lt;/h4>We extracted data from the National Health Insurance Service (NHIS) database in South Korea. As a nationwide database, the NHIS database contains information regarding all disease diagnoses and prescriptions for any drug and/or procedures. A total of 2.5% of adult patients (≥20 years of age) who were diagnosed with musculoskeletal diseases and CNCP from 2010 to 2019 were selected using a stratified random sampling technique and included in the analysis. Patients who were prescribed opioids continuously for ≥90 days were classified as long-term opioid users.&lt;h4>Findings&lt;/h4>A total of 19,645,161 patients with CNCP were included in the final analysis. The prevalence of long-term opioid use was 0.47% (95% confidence interval [CI]: 0.46%, 0.48%; 8421/1,808,043) in 2010, which gradually increased to 2.63% (95% CI: 2.61%, 2.66%; 49,846/1,892,913) in 2019. Among the 2010 cohort (&lt;i>n&lt;/i> = 1,804,019), in multivariable logistic regression: old age, underlying disability, increased Charlson comorbidity index, use of benzodiazepine or Z-drug, rheumatoid arthritis, osteoarthritis, and low back pain were associated with an increased prevalence of long-term opioid use among patients with CNCP. In a multivariable Cox regression, the 10-year all-cause mortality in long-term opioid users was found to be 1·21-fold (hazard ratio: 1.21, 95% CI: 1.13, 1.31; &lt;i&gt;P&lt;/i>&lt;0·001) higher than that in opioid-naive patients with CNCP.&lt;h4>Interpretation&lt;/h4>Long-term opioid use increased in patients with CNCP in South Korea from 2010 to 2019. Certain factors were potential risk factors for long-term opioid use. Moreover, long-term opioid use was associated with increased 10-year all-cause mortality among patients with CNCP.&lt;h4>Funding&lt;/h4>None.</pubmed_abstract><journal>EClinicalMedicine</journal><pagination>101558</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9304910</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-term opioid use and mortality in patients with chronic non-cancer pain: Ten-year follow-up study in South Korea from 2010 through 2019.</pubmed_title><pmcid>PMC9304910</pmcid><pubmed_authors>Oh TK</pubmed_authors><pubmed_authors>Choi HR</pubmed_authors><pubmed_authors>Song IA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term opioid use and mortality in patients with chronic non-cancer pain: Ten-year follow-up study in South Korea from 2010 through 2019.</name><description>&lt;h4>Background&lt;/h4>We aimed to investigate the prevalence and factors associated with long-term opioid use among patients with chronic non-cancer pain (CNCP).&lt;h4>Methods&lt;/h4>We extracted data from the National Health Insurance Service (NHIS) database in South Korea. As a nationwide database, the NHIS database contains information regarding all disease diagnoses and prescriptions for any drug and/or procedures. A total of 2.5% of adult patients (≥20 years of age) who were diagnosed with musculoskeletal diseases and CNCP from 2010 to 2019 were selected using a stratified random sampling technique and included in the analysis. Patients who were prescribed opioids continuously for ≥90 days were classified as long-term opioid users.&lt;h4>Findings&lt;/h4>A total of 19,645,161 patients with CNCP were included in the final analysis. The prevalence of long-term opioid use was 0.47% (95% confidence interval [CI]: 0.46%, 0.48%; 8421/1,808,043) in 2010, which gradually increased to 2.63% (95% CI: 2.61%, 2.66%; 49,846/1,892,913) in 2019. Among the 2010 cohort (&lt;i>n&lt;/i> = 1,804,019), in multivariable logistic regression: old age, underlying disability, increased Charlson comorbidity index, use of benzodiazepine or Z-drug, rheumatoid arthritis, osteoarthritis, and low back pain were associated with an increased prevalence of long-term opioid use among patients with CNCP. In a multivariable Cox regression, the 10-year all-cause mortality in long-term opioid users was found to be 1·21-fold (hazard ratio: 1.21, 95% CI: 1.13, 1.31; &lt;i&gt;P&lt;/i>&lt;0·001) higher than that in opioid-naive patients with CNCP.&lt;h4>Interpretation&lt;/h4>Long-term opioid use increased in patients with CNCP in South Korea from 2010 to 2019. Certain factors were potential risk factors for long-term opioid use. Moreover, long-term opioid use was associated with increased 10-year all-cause mortality among patients with CNCP.&lt;h4>Funding&lt;/h4>None.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T10:47:56.26Z</modification><creation>2025-04-04T10:47:56.26Z</creation></dates><accession>S-EPMC9304910</accession><cross_references><pubmed>35875817</pubmed><doi>10.1016/j.eclinm.2022.101558</doi></cross_references></HashMap>